SpicyIP
  • Log in

  • Home|
  • About Us|
  • Resources|
  • Internship|
  • Fellowship|
  • Contact

De-Coding Indian Intellectual Property Law

Follow us on Facebook Linkedin Twitter Google Plus Facebook

Menu

Skip to content
  • Latest
  • Copyright
  • Patent
  • Trademark
  • Others
    • Design
    • Geographical Indication
    • Plant Variety Protection
    • Biological Diversity
    • Traditional Knowledge
    • Innovation
    • Competition Law
    • Data Exclusivity
    • Drug Regulation
    • Privacy
    • Comparative Advertising
    • View All

Team

Late Prof. (Dr.) Shamnad Basheer Founder & Former Chief Mentor

Pankhuri Agarwal Co-Managing Editor

Swaraj Paul Barooah Co-Managing Editor

Divij Joshi Associate Director

Mathews P. George Expert Analyst

Sreyoshi Guha Expert Analyst

Adarsh Ramanujan Scholar in Practice

Praharsh Gour Student Analyst

Varsha Jhavar Student Analyst

Adyasha Samal Student Fellow

Anupriya Dhonchak Student Fellow

Nikhil Purohit Student Fellow

 

Former Bloggers

Sumathi Chandrasekharan

Adarsh

Duncan Bucknell

Kamakhya

Mrinalini Kochupillai

Suchita Saigal

Shouvik Kumar Guha

Spadika Jayaraj

Thomas J. Vallianeth

Kartik Chawla

Inika Charles

Prateek Surisetti

Aparajita Lath

Rishabh Mohnot

Balu Nair

Arnab Roy

J. Sai Deepak

Kruttika Vijay

Nihad Basheer

Shayonee Dasgupta

Yashasvini Kumar

L. Gopika Murthy

Rupali Samuel

Anubha Sinha

Kiran George

Shan Kohli

Sreyoshi Guha

Devika Agarwal

Prarthana Patnaik

Aysha Shaukat

Jayant Kumar

Mihir Naniwadekar

Prakruthi Gowda

Shwetasree Majumder

Sai Vinod

Amlan Mohanty

Shruthi Chandrasekharan

Madhulika Vishwanathan

Balaji Subramanian

Rahul Bajaj

Rajiv Kumar Choudhry

Latha Nair

Prashant Reddy

 

 

One comment.

  1. Pingback: SpicyIP 2.0: We’re live! | Spicy IP

Comments are closed.

Library

  • All ResourcesAll Resources
  • IP Books - Open AccessIP Books – Open Access
  • IP BooksIP Books
  • A Report on India's Top IP Developments of 2020A Report on India’s Top IP Developments of 2020
  • Prof. (Dr.) Shamnad Basheer - Publications & Public Interest InterventionsProf. (Dr.) Shamnad Basheer – Publications & Public Interest Interventions
  • Most Read Posts on SpicyIP in 2020Most Read Posts on SpicyIP in 2020

Popular Posts

  • Intellectual Property Rights in Covaxin - Part 1 (Waiver of IPRs)Intellectual Property Rights in Covaxin – Part 1 (Waiver of IPRs)
  • Remdesivir Shortage: Can the Drug be Imported under Patents Act?Remdesivir Shortage: Can the Drug be Imported under Patents Act?
  • Intellectual Property Rights in Covaxin – Part 2 (IP Ownership in Publicly Funded Research)Intellectual Property Rights in Covaxin – Part 2 (IP Ownership in Publicly Funded Research)
  • Copyright Rules Amendment 2021: Appellate Board, Copyright Societies, and MoreCopyright Rules Amendment 2021: Appellate Board, Copyright Societies, and More
  • Non-Fungible Tokens (NFT) Sales and Copyright Assignment: Part I (The Contract is the Key)Non-Fungible Tokens (NFT) Sales and Copyright Assignment: Part I (The Contract is the Key)
  • Breaking: President Promulgates Tribunal Reforms (Rationalisation and Conditions of Service) Ordinance 2021Breaking: President Promulgates Tribunal Reforms (Rationalisation and Conditions of Service) Ordinance 2021
  • Non-Fungible Tokens (NFTs) and Copyright Law: A “Nifty” DilemmaNon-Fungible Tokens (NFTs) and Copyright Law: A “Nifty” Dilemma
  • Compulsory License for Covid Drugs on the Table, Says Delhi High CourtCompulsory License for Covid Drugs on the Table, Says Delhi High Court
  • The Compilation of the Decade of SpicyIP Posts on IPABThe Compilation of the Decade of SpicyIP Posts on IPAB
  • A Recipe for Disaster: Export Bans, TRIPS Waiver and Hyper NationalismA Recipe for Disaster: Export Bans, TRIPS Waiver and Hyper Nationalism

IP & COVID-19

  • Intellectual Property Rights in Covaxin - Part 1 (Waiver of IPRs)Intellectual Property Rights in Covaxin – Part 1 (Waiver of IPRs)
  • Remdesivir Shortage: Can the Drug be Imported under Patents Act?Remdesivir Shortage: Can the Drug be Imported under Patents Act?
  • Intellectual Property Rights in Covaxin – Part 2 (IP Ownership in Publicly Funded Research)Intellectual Property Rights in Covaxin – Part 2 (IP Ownership in Publicly Funded Research)
  • Compulsory License for Covid Drugs on the Table, Says Delhi High CourtCompulsory License for Covid Drugs on the Table, Says Delhi High Court
  • A Recipe for Disaster: Export Bans, TRIPS Waiver and Hyper NationalismA Recipe for Disaster: Export Bans, TRIPS Waiver and Hyper Nationalism
  • Indian Govt. Permits Manufacture of Covaxin by Haffkine Institute - But Why Not Others Too?Indian Govt. Permits Manufacture of Covaxin by Haffkine Institute – But Why Not Others Too?
  • Intellectual Property Rights in Covaxin – Part 3 (IP Rights over Clinical Drug Trials (CT) Data)Intellectual Property Rights in Covaxin – Part 3 (IP Rights over Clinical Drug Trials (CT) Data)
  • Fluid Trademarks: An Alter Ego for Brands?Fluid Trademarks: An Alter Ego for Brands?
  • Dainik Jagran Sues Telegram for Copyright Infringement: Are Platforms or Group Admins Liable for Unlawful Speech on Closed Online Forums?Dainik Jagran Sues Telegram for Copyright Infringement: Are Platforms or Group Admins Liable for Unlawful Speech on Closed Online Forums?
  • Tenability of Passing Off Action against 'Covishield' Vaccine of Serum Institute of IndiaTenability of Passing Off Action against ‘Covishield’ Vaccine of Serum Institute of India

Topics

Biological Diversity Comparative Advertising Competition Law Copyright Courses & Workshops COVID-19 Data Exclusivity Design Drug Regulation Event Geographical Indication Innovation Opportunities Others Overlaps in IP Patent Plant Variety Protection Privacy Publication Sponsored Trademark Trade Secret Traditional Knowledge Uncategorized

Opportunities

  • Call for Submissions
  • Courses & Workshops
  • Essay Competitions
  • Fellowships & Scholarships
  • Job & Research Opportunities
  • Moot Court Competitions
  • Patent Drafting & Other Competitions
  • Webinars, Conferences & Other Events

Latest Comments

  • Jagdish Sagar { Interesting post, thanks. Incidentally, there is no fixation requirement in Indian copyright law. Nothing published by the Copyright Office is authoritative. Background: Article 2(2) of the Berne Convention... }
  • Partha { Good Adarsh. very lucidly written. some of my doubts were clarified / my views confirmed. }
  • Abhayan Jawaharlal { Excellent article. One premise on which this article rests is that the development is a co-development. The public notice issued by Bharat Biotech regarding the price of COVAXIN... }
  • Akshat { Best piece and needs to be read by everyone who romanticizes IP today. }
  • Adyasha Samal { Thank you for bringing out that point, sir. Indeed, implementing a mandatory registration system would unfairly deprive Indian authors of the rights that foreign authors would continue to... }

Latest Opportunities

  • NUJS Webinar on ‘IPR& SMEs (Special Focus on Agriculture & Food Sector): Strengthening Bonds in Prime Times’ (April 25) (April 21, 2021)
  • [Sponsored] Seeing It Through: The Journey of the Dean of UNH Franklin Pierce School of Law (April 19, 2021)
  • Call for Chapters: Inclusive Wealth Generation through IP Commercialization (March 23, 2021)
  • UNH Franklin Pierce’s IP Summer Institute 2021 (May 24 – June 11, June 14 – July 2) (March 19, 2021)
  • A Draft “Open” IP Syllabus (February 25, 2021)
  • Call for Papers: NLU Jodhpur’s Journal of Intellectual Property Studies Vol. 4, Issue 2 [Submit by March 21] (January 29, 2021)
  • Patent Drafting Positions at Remfry & Sagar, Bengaluru & Gurgaon (January 20, 2021)
  • LexisNexis Webinar on ‘Understand the Innovation Landscape of Global Video Conference Technology’ [December 23, 2020] (December 18, 2020)

Latest IP & COVID-19 Posts

  • A Recipe for Disaster: Export Bans, TRIPS Waiver and Hyper Nationalism (April 25, 2021)
  • Compulsory License for Covid Drugs on the Table, Says Delhi High Court (April 21, 2021)
  • Indian Govt. Permits Manufacture of Covaxin by Haffkine Institute – But Why Not Others Too? (April 16, 2021)
  • Remdesivir Shortage: Can the Drug be Imported under Patents Act? (April 14, 2021)
  • Intellectual Property Rights in Covaxin – Part 1 (Waiver of IPRs) (March 24, 2021)
  • Tenability of Passing Off Action against ‘Covishield’ Vaccine of Serum Institute of India (January 3, 2021)
  • India on TRIPS Waiver: Will WTO Pass the Test of Humanity? (December 20, 2020)
  • COVID-19 Vaccines: Patent Ownership and the Barriers to Equitable Access (December 2, 2020)
  • Dapagliflozin Injunction Denied: Of Double-Patenting and Coverage-Disclosure Dichotomy (November 19, 2020)
  • Trademark Trolls: Perspectives, Pitfalls and the Way Forward (November 17, 2020)


  • Home |
  • About Us |
  • Archives |
  • Contact |
  • Terms & Conditions|
  • Site maintained by Anant Shrivastava